On the other hand, we chose other lung cancer cell lines, H441 (wild-type EGFR), H3225 (L858R EGFR), H1975 (L858R, T790M EGFR), to test whether the mutations in EGFR could influence the afatinib labeling. The gene discussed is EGFR; the disease is lung cancer.